Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.194
+0.024 (2.05%)
Feb 23, 2026, 9:04 AM EST - Market open
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.14 million as of February 23, 2026. Its market cap has decreased by -67.19% in one year.
Market Cap
2.14M
Enterprise Value
-1.71M
1-Year Change
-67.19%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $2.14M, a decrease of -91.81%. That is a compound annual growth rate of -42.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 2.10M | -22.64% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
| Aug 16, 2021 | 26.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 2.72M |
| Artelo Biosciences | 2.66M |
| SciSparc | 2.66M |
| XORTX Therapeutics | 2.59M |
| Lyra Therapeutics | 2.57M |
| Scinai Immunotherapeutics | 2.50M |
| Bone Biologics | 2.15M |
| CNS Pharmaceuticals | 1.99M |